Latest News

Around the Helix: Cell and Gene Therapy Company Updates – November 20, 2024
Around the Helix: Cell and Gene Therapy Company Updates – November 20, 2024

November 20th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Georg Schett, MD, vice president research and chair of internal medicine at the University of Erlangen – Nuremberg
Georg Schett, MD, on Exploring CAR-T for Autoimmune Disease

November 20th 2024

David Barrett, JD, the chief executive officer of ASGCT
David Barrett, JD, on ASGCT’s Q3 2024 Landscape Report

November 20th 2024

First Patient Dosed in Trial for Adicet's T-Cell Therapy ADI-100 in Autoimmune Disease
First Patient Dosed in Trial for Adicet's T-Cell Therapy ADI-100 in Autoimmune Disease

November 19th 2024

Sophie Olivier, MD, the chief medical officer of Atamyo
Atamyo Therapeutics' Gene Therapy ATA-200 Cleared for US Trial in LGMD Type 2C/R5

November 19th 2024

Video Interviews

Conference Coverage

View All
Georg Schett, MD, vice president research and chair of internal medicine at the University of Erlangen – Nuremberg
Georg Schett, MD, on Exploring CAR-T for Autoimmune Disease

November 20th 2024

Chris Wright, MD, PhD, the chief medical officer and head of translational research at Ring Therapeutics
Anelloviruses, a Potential Alternative to AAV for Gene Therapy

November 12th 2024

Sandi See Tai, MD, chief development officer at Lexeo
Gene Therapy for APOE4 Homozygous Alzheimer Disease

November 6th 2024

 Capsida Biotherapeutics' CAP-003 Displays Properties of Disease-Modification in Preclinical Parkinson Disease Research
Capsida Biotherapeutics' CAP-003 Displays Properties of Disease-Modification in Preclinical Parkinson Disease Research

November 5th 2024

All News

© 2024 MJH Life Sciences

All rights reserved.